Beta glucan / neoplasms

.beta.-glucan methods and compositions that affect the tumor microenvironment

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

BACKGROUND OF THE INVENTION This disclosure relates to combinations of soluble .beta.-glucan and anti-cancer agents that affect the tumor microenvironment, including immunosuppression-relieving anti-cancer agents. .beta.-glucan is a fungal PAMP and is recognized by pattern recognition molecule C3 in

Beta-glucan in combination with anti-cancer agents affecting the tumor microenvironment

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

BACKGROUND OF THE INVENTION The present invention relates to combinations of soluble .beta.-glucan and anti-cancer agents that affect the tumor microenvironment, including immunosuppression-relieving anti-cancer agents. .beta.-glucan is a fungal PAMP and is recognized by pattern recognition molecule

Cancer therapy using beta glucan and antibodies

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

BACKGROUND OF THE INVENTION Beta(.beta.)-glucan is a complex carbohydrate, generally derived from several sources, including yeast, bacteria, fungi and cereal grains. Each type of .beta.-glucan has a unique structure in which glucose is linked together in different ways, resulting in different

Cancer therapy using beta glucan and antibodies

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

BACKGROUND OF THE INVENTION Beta(.beta.)-glucan is a complex carbohydrate, generally derived from several sources, including yeast, bacteria, fungi and cereal grains. Each type of .beta.-glucan has a unique structure in which glucose is linked together in different ways, resulting in different

Radiolabeled glucans which bind to leukocytes, sites of infection, inflammation, atherosclerosis, or cancer

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

BACKGROUND OF THE INVENTION 1. Field of the Invention This invention relates to radiodiagnostic agents and reagents for preparing such agents, and also methods for producing radiolabeled radiodiagnostic agents. Specifically, the invention relates to technetium-99m (.sup.99m Tc) labeled agents,

Compositions comprising selenium-rich yeast and yeast beta-glucan

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

CROSS-REFERENCE TO RELATED APPLICATIONS This application claims priority benefits to Chinese Patent Application No. 200810105513.3 filed on Apr. 29, 2008, the contents of which are incorporated herein by reference. BACKGROUND OF THE INVENTION 1. Field of the Invention The invention relates to a

Compositions and methods for beta-glucan immunotherapy

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

SUMMARY This disclosure describes, in one aspect, a composition that includes a .beta.-glucan component and an antibody component that specifically binds to the .beta.-glucan. In some embodiments, the .beta.-glucan may be derived from yeast. In some embodiments, the .beta.-glucan can include a

Therapeutic liposome and method of treating a subject having cancer

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

BACKGROUND OF THE INVENTION Technical Field The present invention relates to a liposome for treating cancer by including doxorubicin, a polyunsaturated fatty acid, and beta glucan in combination. Description of the Related Art The "background" description provided herein is for the purpose of

Radiolabeled glucans covalently linked to a radiolabel binding moiety

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

BACKGROUND OF THE INVENTION 1. Field of the Invention This invention relates to radiodiagnostic agents and reagents for preparing such agents, and also methods for producing radiolabeled radiodiagnostic agents. Specifically, the invention relates to technetium-99m (.sup.99m Tc) labeled agents,

Radiolabled glucans covalently linked to a radiometal binding moiety

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

BACKGROUND OF THE INVENTION 1. Field of the Invention This invention relates to radiodiagnostic agents and reagents for preparing such agents, and also methods for producing radiolabeled radiodiagnostic agents. Specifically, the invention relates to technetium-99m (.sup.99m Tc) labeled agents,

Radiolabeled glucans covalently linked to a radiolabel binding moiety

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

BACKGROUND OF THE INVENTION 1. Field of the Invention This invention relates to radiodiagnostic agents and reagents for preparing such agents, and also methods for producing radiolabeled radiodiagnostic agents. Specifically, the invention relates to technetium-99m (.sup.99m Tc) labeled agents,

Process of preparing biologically active substance

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a biologically active substance recovered from the mycelium and fruit body of Agaricus blazei; and a process of preparing the biologically active substance. 2. Description of the Prior Art Agaricus blazei is a

Biologically active substance and process of preparing the same

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a biologically active substance recovered from the mycelium and fruit body of Agaricus blazei; and a process of preparing the biologically active substance. 2. Description of the Prior Art Agaricus blazei is a

Therapy-enhancing glucan

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

Throughout this application, various references are cited. Disclosures of these publications in their entireties are hereby incorporated by reference into this application to more fully describe the state of the art to which this invention pertains. BACKGROUND OF THE INVENTION Beta-glucans have been

Therapy-enhancing glucan

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

Throughout this application, various references are cited. Disclosures of these publications in their entireties are hereby incorporated by reference into this application to more fully describe the state of the art to which this invention pertains. BACKGROUND OF THE INVENTION Monoclonal antibodies

beta glucan/neoplasms

.beta.-glucan methods and compositions that affect the tumor microenvironment

Beta-glucan in combination with anti-cancer agents affecting the tumor microenvironment

Cancer therapy using beta glucan and antibodies

Cancer therapy using beta glucan and antibodies

Radiolabeled glucans which bind to leukocytes, sites of infection, inflammation, atherosclerosis, or cancer

Compositions comprising selenium-rich yeast and yeast beta-glucan

Compositions and methods for beta-glucan immunotherapy

Therapeutic liposome and method of treating a subject having cancer

Radiolabeled glucans covalently linked to a radiolabel binding moiety

Radiolabled glucans covalently linked to a radiometal binding moiety

Radiolabeled glucans covalently linked to a radiolabel binding moiety

Process of preparing biologically active substance

Biologically active substance and process of preparing the same

Therapy-enhancing glucan

Therapy-enhancing glucan

Den mest kompletta databasen med medicinska örter som stöds av vetenskapen